Martek to Present at Upcoming UBS Conference

Thursday, May 22, 2008 General News
Email Print This Page Comment
Font : A-A+

COLUMBIA, Md., May 21 Martek BiosciencesCorporation (Nasdaq: MATK) announced today that it will be presenting at the2008 UBS Global Generic and Specialty Pharmaceuticals Conference in London.The conference is being held May 28 -- 29, 2008 at the Waldorf Hilton,Aldwych, London. Steve Dubin, CEO will be presenting on Wednesday, May 28,2008 at 9:00 a.m. EDT (2:00 p.m. London Time).

Interested parties may access a live audio webcast of Martek'spresentation through the UBS website at:http://www.ibb.ubs.com/Conferences/co_highlights.shtml

Martek Biosciences Corporation (Nasdaq: MATK) is a leader in theinnovation and development of DHA omega-3 products that promote health andwellness through every stage of life. The company produces life'sDHA(TM), asustainable and vegetarian source of the omega-3 fatty acid DHA(docosahexaenoic acid), for use in foods, beverages, infant formula, andsupplements. The company also produces life'sARA(TM) (arachidonic acid), anomega-6 fatty acid, from a sustainable, vegetarian source, for use in infantformula. For more information on Martek Biosciences Corporation, visithttp://www.martek.com.

Contact: Kyle StultsInvestor Relations (410) 740-0081

SOURCE Martek Biosciences Corporation


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook